Creating a paradigm shift in Tuberculosis (TB) diagnostics with an ultra-sensitive, rapid, specific & automated system to compete in the $3B annual market.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free